Literature DB >> 26163338

Phytochemical uptake following human consumption of Montmorency tart cherry (L. Prunus cerasus) and influence of phenolic acids on vascular smooth muscle cells in vitro.

Karen M Keane1, Phillip G Bell1, John K Lodge1, Costas L Constantinou1, Sarah E Jenkinson1, Rosemary Bass1, Glyn Howatson2,3.   

Abstract

PURPOSE: To investigate the phytochemical uptake following human consumption of Montmorency tart cherry (L. Prunus cerasus) and influence of selected phenolic acids on vascular smooth muscle cells in vitro.
METHODS: In a randomised, double-blinded, crossover design, 12 healthy males consumed either 30 or 60 mL of Montmorency tart cherry concentrate. Following analysis of the juice composition, venous blood samples were taken before and 1, 2, 3, 5 and 8 h post-consumption of the beverage. In addition to examining some aspects of the concentrate contents, plasma concentrations of protocatechuic acid (PCA), vanillic acid (VA) and chlorogenic (CHL) acid were analysed by reversed-phase high-performance liquid chromatography (HPLC) with diode array for quantitation and mass spectrometry detection (LCMS) for qualitative purposes. Vascular smooth muscle cell migration and proliferation were also assessed in vitro.
RESULTS: Both the 30 and 60 mL doses of Montmorency cherry concentrate contained high amounts of total phenolics (71.37 ± 0.11; 142.73 ± 0.22 mg/L) and total anthocyanins (62.47 ± 0.31; 31.24 ± 0.16 mg/L), as well as large quantities of CHL (0.205 ± 0.24; 0.410 ± 0.48 mg/L) and VA (0.253 ± 0.84; 0.506 ± 1.68 mg/L). HPLC/LCMS identified two dihydroxybenzoic acids (PCA and VA) in plasma following MC concentrate consumption. Both compounds were most abundant 1-2 h post-initial ingestion with traces detectable at 8 h post-ingestion. Cell migration was significantly influenced by the combination of PCA and VA, but not in isolation. There was no effect of the compounds on cell proliferation.
CONCLUSIONS: These data show new information that phenolic compounds thought to exert vasoactive properties are bioavailable in vivo following MC consumption and subsequently can influence cell behaviour. These data may be useful for the design and interpretation of intervention studies investigating the health effects of Montmorency cherries.

Entities:  

Keywords:  Bioavailability; Cell behaviour; Montmorency; Phenolic acids; Recovery

Mesh:

Substances:

Year:  2015        PMID: 26163338     DOI: 10.1007/s00394-015-0988-9

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  34 in total

1.  Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.

Authors:  Glyn Howatson; Phillip G Bell; Jamie Tallent; Benita Middleton; Malachy P McHugh; Jason Ellis
Journal:  Eur J Nutr       Date:  2011-10-30       Impact factor: 5.614

Review 2.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

3.  Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries.

Authors:  N P Seeram; R A Momin; M G Nair; L D Bourquin
Journal:  Phytomedicine       Date:  2001-09       Impact factor: 5.340

4.  Processed tart cherry products--comparative phytochemical content, in vitro antioxidant capacity and in vitro anti-inflammatory activity.

Authors:  Boxin Ou; Kristen N Bosak; Paula R Brickner; Dominic G Iezzoni; E Mitchell Seymour
Journal:  J Food Sci       Date:  2012-05       Impact factor: 3.167

5.  Vanillin as an antioxidant in rat liver mitochondria: inhibition of protein oxidation and lipid peroxidation induced by photosensitization.

Authors:  J P Kamat; A Ghosh; T P Devasagayam
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

6.  Influence of tart cherry juice on indices of recovery following marathon running.

Authors:  G Howatson; M P McHugh; J A Hill; J Brouner; A P Jewell; K A van Someren; R E Shave; S A Howatson
Journal:  Scand J Med Sci Sports       Date:  2010-12       Impact factor: 4.221

7.  Impact of dose on the bioavailability of coffee chlorogenic acids in humans.

Authors:  Angélique Stalmach; Gary Williamson; Alan Crozier
Journal:  Food Funct       Date:  2014-08       Impact factor: 5.396

8.  Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption.

Authors:  Angélique Stalmach; William Mullen; Denis Barron; Kenichi Uchida; Takao Yokota; Christophe Cavin; Heike Steiling; Gary Williamson; Alan Crozier
Journal:  Drug Metab Dispos       Date:  2009-05-21       Impact factor: 3.922

9.  Chlorogenic acids from green coffee extract are highly bioavailable in humans.

Authors:  Adriana Farah; Mariana Monteiro; Carmen M Donangelo; Sophie Lafay
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

10.  The pharmacokinetics of anthocyanins and their metabolites in humans.

Authors:  R M de Ferrars; C Czank; Q Zhang; N P Botting; P A Kroon; A Cassidy; C D Kay
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

View more
  24 in total

1.  Cardiovascular function during supine rest in endurance-trained males with New Zealand blackcurrant: a dose-response study.

Authors:  Matthew David Cook; Stephen David Myers; Mandy Lucinda Gault; Victoria Charlotte Edwards; Mark Elisabeth Theodorus Willems
Journal:  Eur J Appl Physiol       Date:  2016-12-24       Impact factor: 3.078

2.  Tart cherry (Prunus cerasus L.) dietary supplement modulates visceral adipose tissue CB1 mRNA levels along with other adipogenesis-related genes in rat models of diet-induced obesity.

Authors:  Paolo Cocci; Michele Moruzzi; Ilenia Martinelli; Federica Maggi; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Gilberto Mosconi; Seyed Khosrow Tayebati; Silvia Damiano; Giulio Lupidi; Consuelo Amantini; Daniele Tomassoni; Francesco Alessandro Palermo
Journal:  Eur J Nutr       Date:  2021-01-02       Impact factor: 5.614

3.  Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight, middle-aged men.

Authors:  Zainie Aboo Bakkar; Jonathan Fulford; Phillip E Gates; Sarah R Jackman; Andrew M Jones; Bert Bond; Joanna L Bowtell
Journal:  J Appl Physiol (1985)       Date:  2018-11-29

Review 4.  The Benefits of Anthocyanins against Obesity-Induced Inflammation.

Authors:  Chanya Ngamsamer; Jintana Sirivarasai; Nareerat Sutjarit
Journal:  Biomolecules       Date:  2022-06-20

Review 5.  A Review of the Health Benefits of Cherries.

Authors:  Darshan S Kelley; Yuriko Adkins; Kevin D Laugero
Journal:  Nutrients       Date:  2018-03-17       Impact factor: 5.717

6.  Development and evaluation of floating alginate microspheres for oral delivery of anthocyanins - A preliminary investigation.

Authors:  Giovana B Celli; Amyl Ghanem; Marianne S Brooks
Journal:  Food Sci Nutr       Date:  2016-12-21       Impact factor: 2.863

7.  Effects of short-term continuous Montmorency tart cherry juice supplementation in participants with metabolic syndrome.

Authors:  Terun Desai; Michael Roberts; Lindsay Bottoms
Journal:  Eur J Nutr       Date:  2020-08-12       Impact factor: 5.614

8.  Tart Cherry (Fruit of Prunus cerasus) Concentrated Powder (TCcp) Ameliorates Glucocorticoid-Induced Muscular Atrophy in Mice.

Authors:  Sae-Kwang Ku; Jong-Min Lim; Hyung-Rae Cho; Khawaja Muhammad Imran Bashir; Young Suk Kim; Jae-Suk Choi
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

9.  The Effects of Montmorency Tart Cherry Concentrate Supplementation on Recovery Following Prolonged, Intermittent Exercise.

Authors:  Phillip G Bell; Emma Stevenson; Gareth W Davison; Glyn Howatson
Journal:  Nutrients       Date:  2016-07-22       Impact factor: 5.717

10.  Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.

Authors:  Sophie N B Selby-Pham; Rosalind B Miller; Kate Howell; Frank Dunshea; Louise E Bennett
Journal:  Sci Rep       Date:  2017-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.